FABP1 and metabolic dysfunction-associated steatotic liver disease: In the liver of mice with FABP1 silencing (30) and FABP1-deficient mice with NAFLD (31), deficient FABP1 expression not only led to weight decline and decreased triglyceride content in the liver but also suppressed the expression of hepatic inflammatory cytokines.